Medistim ASASTU:MD1 -0.99%92 FCF Margin % is 3.58% as of Mar. 2026, which is 80% below its 10-year median of 18.26. GuruFocus rates STU:MD1 with a GF Score™ of 92/100 and a GF Value™ of €22.94. The stock has 1 warning sign investors should review. Among 815 Medical Devices & Instruments companies, Medistim ASA ranks better than 94.6% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Medistim ASA's Free Cash Flow for the
three
months ended in Mar. 2026 was €0.65 Mil. Medistim ASA's Revenue for the
three
months ended in Mar. 2026 was €18.06 Mil. Therefore, Medistim ASA's FCF Margin % for the quarter that ended in Mar. 2026 was 3.58%.
The historical rank and industry rank for Medistim ASA's FCF Margin % or its related term are showing as below:
STU:MD1'
s FCF Margin % Range Over the Past 10 Years
Min: 6.48 Med: 18.26 Max: 27.74
Current: 24.69
During the past 13 years, the highest FCF Margin % of Medistim ASA was 27.74%. The lowest was 6.48%. And the median was 18.26%.
STU:MD1's FCF Margin % is ranked better than 94.6% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: -0.03
vs STU:MD1: 24.69
Medistim ASA FCF Margin % Related Terms
Medistim ASA FCF Margin % Historical Data
* Premium members only.
The historical data trend for Medistim ASA's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Medistim ASA's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medistim ASA FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medistim ASA's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Medistim ASA's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medistim ASA (STU:MD1) has a FCF Margin % of 3.58% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Medistim ASA and its competitors. This is 80% below median its historical median of 18.26. Over the past decade, Medistim ASA's FCF Margin % has ranged from 6.48 to 27.74. According to the industry distribution chart, Medistim ASA ranks #44 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 5.4%.
Is Medistim ASA's FCF Margin % too high?
Medistim ASA's current FCF Margin % of 3.58% is 80% below median its 10-year median of 18.26. Over the past 10 years, this metric has ranged from a low of 6.48 to a high of 27.74. Based on the distribution chart, Medistim ASA ranks #44 out of 815 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Medistim ASA has a GF Score™ of 92/100, reflecting its overall financial health beyond just this single metric.
How does Medistim ASA's FCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Medistim ASA ranks #44 out of 815 companies for FCF Margin %. This places Medistim ASA in the top 5% of its industry — outperforming the majority of peers. Historically, Medistim ASA's own FCF Margin % has ranged from 6.48 to 27.74 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Medistim ASA and its competitors. Medistim ASA's current FCF Margin % is 3.58%, which is 80% below median its own 10-year median of 18.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medistim ASA stock overvalued right now?
Medistim ASA (STU:MD1) has a current FCF Margin % of 3.58%. The stock's GF Value™ is €22.94, compared to a current price of €20.10 — trading 12.4% below its estimated fair value. The current FCF Margin % is 3.58%, which is 80% below median its 10-year median of 18.26. Medistim ASA's overall GF Score™ is 92/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Medistim ASA (STU:MD1), the current FCF Margin % is 3.58% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medistim ASA (STU:MD1) Overvalued in 2026?
Based on GuruFocus' analysis, Medistim ASA stock appears to be undervalued.
The current stock price of €20.10 is trading 12.4% below its estimated GF Value™ of €22.94.
Key valuation signals for STU:MD1:
FCF Margin %: 3.58% (80% below median its 10-year median of 18.26)
GF Value™: €22.94 vs. price of €20.10 (12.4% below fair value)
No single metric tells the full story. See the STU:MD1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medistim ASA is a medical device company. It is engaged in researching, developing, producing, distributing, and sales of medical equipment through its own business or participation in other companies, as well as related activities. The company's business is focused on cardiac and vascular surgery. The group operates in the USA, Europe, China, and the Rest of the World. The main divisions are sale of own products and sale of third-party products. Sale of own products has two business models, the capital model and the lease model. Third-party products segment sells medical devices from third party manufacturers in Norway, Sweden and Denmark. Key revenue is generated from Own Products segment.
92GF Score
Get the complete analysis for STU:MD1
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:MD1 has been successfully added to your 
